Veracyte Inc (VCYT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Sales | 517,145 | 445,764 | 361,051 | 296,536 | 219,514 |
| Cost of Goods | 154,613 | 147,619 | 131,367 | 120,855 | 74,400 |
| Gross Profit | 362,532 | 298,145 | 229,684 | 175,681 | 145,114 |
| Operating Expenses | 305,368 | 282,622 | 315,846 | 217,617 | 227,417 |
| Operating Income | 57,777 | 16,142 | -85,795 | -41,081 | -81,903 |
| Other Income | 10,424 | 9,602 | 9,183 | 4,654 | 254 |
| Pre-tax Income | 68,201 | 25,744 | -76,612 | -36,427 | -81,649 |
| Income Tax | 1,848 | 1,606 | -2,208 | 133 | -6,086 |
| Net Income Continuous | 66,353 | 24,138 | -74,404 | -36,560 | -75,563 |
| Net Income | $66,353 | $24,138 | $-74,404 | $-36,560 | $-75,563 |
| EPS Basic Total Ops | 0.84 | 0.32 | -1.02 | -0.51 | -1.11 |
| EPS Basic Continuous Ops | 0.84 | 0.32 | -1.02 | -0.51 | -1.11 |
| EPS Diluted Total Ops | 0.82 | 0.31 | -1.02 | -0.51 | -1.11 |
| EPS Diluted Continuous Ops | 0.82 | 0.31 | -1.02 | -0.51 | -1.11 |
| EPS Diluted Before Non-Recurring Items | N/A | 0.73 | -0.28 | -0.51 | -0.49 |
| EBITDA(a) | $75,922 | $39,247 | $-59,075 | $-15,153 | $-62,310 |